FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/05/033777 [Registered on: 24/05/2021] Trial Registered Prospectively
Last Modified On: 21/12/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Preventive
Physiotherapy (Not Including YOGA)
Process of Care Changes
Behavioral
Nutraceutical 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to study the effects of Enhanced recovery after surgery protocol vs conventional care surgery in patients undergoing open Radical cystectomy with ileal conduit. 
Scientific Title of Study   Effect of enhanced recovery after surgery (ERAS)protocol in patients undergoing radical cystectomy and urinary diversion: A randomised controlled trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anup Biswas 
Designation  SR 
Affiliation  PGIMER 
Address  Urology Office,Advance Urology Centre,Level 2,Nehru Hospital,PGIMER Sector 12,PGIMER,Chandigarh,160012 Chandigarh CHANDIGARH 160012 India
PGIMER, MDH,H111 Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  09681152697  
Fax    
Email  anup4cnmc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  PROF SK SINGH 
Designation  PROFESSOR AND H.O.D,UROLOGY DEPARTMENT, 
Affiliation  PGIMER 
Address  Urology Office,Advance Urology Centre,Level 2,Nehru Hospital,PGIMER Sector 12,PGIMER,Chandigarh,160012 Chandigarh CHANDIGARH 160012 India

Chandigarh
CHANDIGARH
160012
India 
Phone  7087009326  
Fax    
Email  shrawanksingh2002@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DR SUDHEER K DEVANA 
Designation  ASSOCIATE PROFESSOR 
Affiliation  PGIMER 
Address  Urology Office,Advance Urology Centre,Level 2,Nehru Hospital,PGIMER Sector 12,PGIMER,Chandigarh,160012 Chandigarh CHANDIGARH 160012 India

Chandigarh
CHANDIGARH
160012
India 
Phone  7087008969  
Fax    
Email  drsudheer1983@gmail.com  
 
Source of Monetary or Material Support  
PGIMER,Sector 12,Chandigarh,160012-India 
 
Primary Sponsor  
Name  PGIMER 
Address  PGIMER Sector 12,PGIMER,Chandigarh,160012 Chandigarh CHANDIGARH 160012 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ANUP BISWAS  PGIMER  advance urology ward , level-2, 26 no ward , block B, PGIMER,Sector 12,PGIMER,Chandigarh,160012 Chandigarh CHANDIGARH 160012 India
Chandigarh
CHANDIGARH 
9681152697

anup4cnmc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee PGIMER Chandigarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C679||Malignant neoplasm of bladder, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  conventional surgical care group  Patients will be enrolled in the study with their complete knowledge, patient will be randomised into two groups , one group following ERAS protocol and other group following conventional surgical care, then two groups will be compared in terms of various post operative outcome. Conventional Surgical Care Group will have thromboembolic prophylaxis by DVT stocking , removal of drain iF drain output LESS THAN 50 ML,with NASOGASTRIC TUBE till return of bowel sounds ,NO SHAM FEEDING, INITIATION OF ORAL LIQUIDS AND SOLID WHEN BOWEL SOUNDS RETURNS , compared to ERAS group. 
Intervention  ERAS Group  1. Patients will be enrolled in the study with their complete knowledge, patient will be randomised into two groups , one group following ERAS protocol and other group following conventional surgical care, then two groups will be compared in terms of various post operative outcome. ERAS Group will undergo carbohydrate loading, pharmocological thromboembolic prophylaxis, early removal of drain irrespective of drain output after seeing drain fluid creatinine,without NASOGASTRIC TUBE ,SHAM FEEDING, EARLY INITIATION OF ORAL LIQUIDS AND SOLID as tolerated by the patient , compared to conventional surgical care group. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  ALL PATIENTS UNDERGOING OPEN RADICAL CYSTECTOMY WITH URINARY DIVERSION 
 
ExclusionCriteria 
Details  1. Patients who will not give consent for inclusion in the study
2. History of prior radiotherapy
3. Patients planned for retentive diversions like ONB or CCD
4. Patient with other concomitant malignancy
5. patient with mental and cognitive disease
6. Patient with gastrointestinal disease affecting feeding
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effect of ERAS on length of hospital stay  Primary outcome will be variable according to recovery of patient 
 
Secondary Outcome  
Outcome  TimePoints 
1. Time to appearance of bowel movement and passage of flatus
2. Time to drain removal
3. Peri-operative complications according to Clavien-Dindo classification
4. 30 day Readmission rate
 
30DAYS 
 
Target Sample Size   Total Sample Size="54"
Sample Size from India="54" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/06/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details
Modification(s)  
Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomised ,parallel group  trial , comparing effect of enhanced recovery after surgery (ERAS)protocol in patients undergoing radical cystectomy and urinary diversion  in 54 patients  for 14 months , will be conducted in P.G.I.M.E&R, CHANDIGARH,INDIA.The primary outcome measures effect of ERAS on length of  hospital stay  and secondary outcomes measures  time to appearence of bowel movement and passage of flatus and stool, time to drain removal, perioperative complication according to clavien dindo classification , 30 days readmission rate . 
Close